生命科学资讯

J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma

Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment

Mirum gains a hepatitis D drug in $620M buyout of startup Bluejay

Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar

How digital companion apps unlock value across the drug lifecycle

At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma

Vertex CRISPR therapy hits early goal in children with blood disorders

RFK Jr.’s hand-picked panel questions childhood vaccine schedule

Hemophilia gene therapies are struggling on the market, even as innovation soars

Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use

CDC panel again postpones vote on newborns’ hepatitis B shot

An Arch-backed biotech raises $53M to fight neurodegeneration

12 former FDA chiefs blast Prasad’s move to toughen vaccine standards

Tracey Beth Høeg, top Makary deputy, named head of FDA drug office

UniQure slides further on outlook for Huntington’s gene therapy

After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis

Capricor soars on positive results for Duchenne cell therapy

Pharvaris’ pill succeeds in late-stage trial for rare swelling disorder

Richard Pazdur, FDA drug czar, to retire from agency

FDA details plan to scale back animal tests for some antibody drugs